Mark Heise is the Associate Director of Biostatistics at CSL Behring, where they provide statistical leadership for CSL112, overseeing the clinical development program and Phase 3 study design. They previously held the position of Senior Director of Statistics at Novartis Oncology, leading statistical efforts for Votrient. With extensive experience in managing statistical teams and contributions to major projects at companies like GSK and Procter & Gamble Pharmaceuticals, Mark has consistently demonstrated expertise in clinical development and regulatory submissions. They earned a Ph.D. in Statistics from Virginia Tech and a Bachelor's Degree in Mathematics from Messiah College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices